iRhythm Holdings, Inc. (IRTC)
iRhythm Holdings, Inc. (IRTC) from its SEC filings: 2025 revenue $747.1 million (+26% vs the year before), net margin -6%, free cash flow $34.5 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $747.1 million |
| Revenue growth | +26% |
| Net income | -$45.0 million |
| Net margin | -6.0% |
| Free cash flow | $34.5 million |
| Diluted EPS | $-1.39 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +20% |
| Cash | $246.7 million |
| Long-term debt | $35.0 million |
| Share count, 1 year | +3% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.